Skip to main content

Advertisement

SpringerLink
Log in

Pyridazin-3(2H)-ones: the versatile pharmacophore of medicinal significance

  • Review Article
  • Published:
Medicinal Chemistry Research Aims and scope Submit manuscript

Abstract

Pyridazin-3(2H)-one derivatives have attracted the attention of medicinal chemists during the last decade due to their diverse pharmacological activities. Easy functionalization of various ring positions of pyridazinones makes them an attractive synthetic building block for designing and synthesis of new drugs. The incorporation of this versatile biologically accepted pharmacophore in established medicinally active molecules results in wide range of pharmacological effects. Pyridazinones constitute an interesting group of compounds, many of which possess wide spread pharmacological properties such as antihypertensive, platelet aggregation inhibitory, cardiotonic activities and some are also well known for their pronounced analgesic, anti-inflammatory, antinociceptive, and antiulcer activities. Recently pyridazinones have also been reported as antidiabetic, anticonvulsant, antiasthmatic, and antimicrobial agents. These encouraging reports suggest that this privileged skeleton should be extensively studied for the therapeutic benefits. In view of this, a detailed and updated account of the pharmacological properties of pyridazinones is described in this review. The wide range of synthesized pyridazinone analogs along with their medicinal significance is also presented.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

References

  • Ajiro Y, Hagiwara N, Katsube Y, Sperelakis N, Kasanuki H (2002) Levosimendan increases L-type Ca2+ current via phosphodiesterase-3 inhibition in human cardiac myocytes. Eur J Pharmacol 435:27–33

    Article  PubMed  CAS  Google Scholar 

  • Allen JR, George R, Hanifin JR, John W, Moran DB, Albright J (1985) Substituted phenyl-1,2,4-triazolo[2,3-b]pyridazin-3(2H)ones as antiasthma agents. United States Patent 451591

  • Bansal R, Kumar D, Carron R, Calle CDL (2009) Synthesis and vasodilatory activity of some amide derivatives of 6-(4-carboxymethyloxyphenyl)-4,5-dihydro-3(2H)-pyridazinone. Eur J Med Chem 44:4441–4447

    Article  PubMed  CAS  Google Scholar 

  • Barbaro R, Betti L, Botta M, Corelli F, Giannaccini G, Maccari L, Manetti F, Strappaghetti G, Corsano S (2001) Synthesis, biological evaluation, and pharmacophore generation of new pyridazinone derivatives with affinity towards α1- and α2-adrenoceptors. J Med Chem 44:2118–2132

    Article  PubMed  CAS  Google Scholar 

  • Betti L, Floridi M, Giannaccini G, Manetti F, Strappaghetti G, Tafi A, Botta M (2003) α1-Adrenoceptor antagonists. pyridazinone-arylpiperazines, probing the influence on affinity and selectivity of both ortho-alkoxy groups at the arylpiperazine moiety and cyclic substituents at the pyridazinone nucleus. Bio Org Med Chem Lett 13:171–173

    Article  CAS  Google Scholar 

  • Biagini P, Biancalani C, Graziano A, Cesari N, Giovannoni MP, Cilibrizzi A, Dal Piaz V, Vergelli C, Crocetti L, Delcanale M, Armani E, Rizzi A, Puccini P, Gallo PM, Spinabelli D, Caruso P (2010) Functionalized pyrazoles and pyrazolo[3,4-d]pyridazinones: synthesis and evaluation of their phosphodiesterase 4 inhibitory activity. Bioorg Med Chem Lett 18:3506–3517

    Article  CAS  Google Scholar 

  • Bowman P, Haikala H, Paul RJ (1999) Levosimendan, a calcium sensitizer in cardiac muscle, induces relaxation in coronary smooth muscle through calcium desensitization. J Pharmacol Exp Ther 288:316–325

    PubMed  CAS  Google Scholar 

  • Bristol JA, Sircar I, Moos WH, Evans DB, Weishaar RE (1984) Cardiotonic agents. 1. 4,5-Dihydro-6-[4-(1H-imidazol-1-yl)phenyl]-3(2H)-pyridazinones: novel positive inotropic agents for the treatment of congestive heart failure. J Med Chem 27:1099–1101

    Article  PubMed  CAS  Google Scholar 

  • Cao S, Qian X, Song G, Chai B, Jaang Z (2003) Synthesis and antifeedant activity of new oxadiazolyl 3(2H)-pyridazinones. J Agri Food Chem 51:152–155

    Article  CAS  Google Scholar 

  • Chen HZ, Cui XL, Zhao HC, Zhao LY, Lu JY, Wu BW (2004a) Inotropic effects of MCI-154 on rat cardiac myocytes. Sheng Li Xue Bao 56:301–305

    PubMed  CAS  Google Scholar 

  • Chen H, Cui X, Guo W, Zhao H, Zhao L, Lu J, Wu B (2004b) Positive inotropic effect of MCI-154 on hypertrophied heart of rats and its mechanisms. Zhongguo Yaolixue Yu Dulixue Zazhi 18:338–343

    CAS  Google Scholar 

  • Cherng SC, Huang HW, Shiau CY, Lee AR, Chou TC (2006) Mechanisms of antiplatelet activity of PC-09: a newly synthesized pyridazinone derivative. Eur J Pharmacol 532:32–37

    Article  PubMed  CAS  Google Scholar 

  • Chintakunta VK, Akella V, Vedula MS, Mamnoor PK, Mishra P, Casturi SR, Vangoori A, Rajagopalan R (2002) 3-O-substituted benzyl pyridazinone derivatives as COX inhibitors. Eur J Med Chem 37:339–347

    Article  PubMed  CAS  Google Scholar 

  • Cinone N, Carrieri G, Strappaghetti G, Corsano S, Barbaro R, Carotti A (1999) Comparative molecular field analysis of some pyridazinone-containing α1-anatagonists. Bio Org Med Chem 7:2615–2620

    Article  CAS  Google Scholar 

  • Coates WJ (1996) Pyridazines and their benzo derivatives. In: Katritzky AR, Rees CW, Scriven EFW (eds) Comprehensive heterocyclic chemistry, vol 6. Pergamon Press, Oxford, New York, pp 86–89

    Google Scholar 

  • Combs DW, Rampulla MS, Bell SC, Klaubert DH, Tobia AJ, Falotico R, Haertlein B, Moore JB (1990) 6-Benzoxazinyl- pyridazin-3-ones: potent, long-acting positive inotrope and peripheral vasodilator agents. J Med Chem 33:380–386

    Article  PubMed  CAS  Google Scholar 

  • Costantino L, Rastelli G, Gamberini MC, Giovannoni MP, Dal Piaz V, Vianello P, Barlocco D (1999) Isoxazolo-[3,4-d]-pyridazin-7-(6H)-one as a potential substrate for new aldose reductase inhibitors. J Med Chem 42:1894–1900

    Article  PubMed  CAS  Google Scholar 

  • Curran CV, Ross A (1974) 6-Phenyl-4,5-dihydro-3(2H)-pyridazinones. A series of hypotensive agents. J Med Chem 17:273–281

    Article  PubMed  CAS  Google Scholar 

  • Dal Piaz V, Ciciani G, Giovannoni MP (1994) 4,5-Functionalized-3(2H)-pyridazinones: new synthetic and pharmacological aspects. Acta Chim Slov 41:189–203

    CAS  Google Scholar 

  • Dal Piaz V, Giovannoni MP, Ciciani G, Barlocco D, Giardina G, Petrone G, Clarke GD (1996) 4,5-Functionalized 6-phenyl-3(2H)-pyridazinones: synthesis and evaluation of antinociceptive activity. Eur J Med Chem 31:65–70

    Article  CAS  Google Scholar 

  • Dal Piaz V, Rascon A, Dubra ME, Giovannoni MP, Vergelli C, Castellana MC (2002) Isoxazolo[3,4-d]pyridazinones and analogues as Leishmania mexicana PDE inhibitors. IL Farmaco 57:89–96

    Article  PubMed  CAS  Google Scholar 

  • Dal Piaz V, Vergelli C, Giovannoni MP, Scheideler MA, Petrone G, Zaratin P (2003) 4-Amino-3(2H)-pyridazinones bearing arylpiperazinylalkyl groups and related compounds: synthesis and antinociceptive activity. IL Farmaco 58:1063–1071

    Article  CAS  Google Scholar 

  • Demirayak S, Karaburun AC, Beis R (2004) Some pyrrole substituted aryl pyridazinone and phthalazinone derivatives and their antihypertensive activities. Eur J Med Chem 39:1089–1095

    Article  PubMed  CAS  Google Scholar 

  • Dogruer DS, Sahin ME (2003) Synthesis, analgesic and anti-inflammatory activity of new pyridazinones. Turk J Chem 27:727–738

    CAS  Google Scholar 

  • Fitton A, Brogden RN (1994) Pimobendan. A review of its pharmacology and therapeutic potential in congestive heart failure. Drugs Aging 4:417–441

    Article  PubMed  CAS  Google Scholar 

  • Giovannoni MP, Dal Piaz V, Kwon BM, Kim MK, Toma L, Kwon BM, Kim MK, Kim YK, Toma L, Barlocco D, Bernini F, Canavesi M (2001) 5,6-Diphenylpyridazine derivatives as Acyl-CoA: cholesterol acyltransferase inhibitors. J Med Chem 44:4292–4295

    Article  PubMed  CAS  Google Scholar 

  • Gokce M, Dogruer D, Sahin MF (2001) Synthesis and antinociceptive activity of 6-substituted-3-pyridazinone derivatives. IL Farmaco 56:233–237

    Article  PubMed  CAS  Google Scholar 

  • Gokce M, Sahin MF, Kupeli E, Yesilada E (2004) Synthesis and evaluation of the analgesic and anti-inflammatory activity of new 3(2H)-pyridazinone derivatives. Arzneim-Forsch 54:396–401

    CAS  Google Scholar 

  • Gokce M, Utku S, Kupeli E (2009) Synthesis and analgesic and anti-inflammatory activities 6-substituted-3(2H)- pyridazinone-2-acetyl-2-(p substituted /nonsubstituted benzal) hydrazone derivatives. Eur J Med Chem 44:3760–3764

    Article  PubMed  Google Scholar 

  • Harris R, Black L, Surapaneni S, Kolasa T, Majest S (2004) ABT-963 [2-(3,4-Difluorophenyl)-4(3-hydroxy-3-methylbutoxy)-5-(4-methanesulphonyl-phenyl)-2H-pyridazin-3-one], a highly potent and selective disubstituted pyridazinone cyclooxygenase-2 inhibitor. J Pharmacol Exp Ther 311:904–912

    Article  PubMed  CAS  Google Scholar 

  • Heinisch G, Frank H (1990) Pharmacologically active pyridazine derivatives. Part 2. In: Ellis GP, West GB (eds) Progress in medicinal chemistry, 27th edn. Elsevier, Amsterdam, p 1

    Google Scholar 

  • Heinisch G, Frank H (1992) Pharmacologically active pyridazine derivatives. Part 2. In: Ellis GP, West GB (eds) Progress in medicinal chemistry, 29th edn. Elsevier, Amsterdam, pp 141–183

    Google Scholar 

  • Innes CA, Wagstaff AJ (2003) Levosimendan: a review of its use in the management of acute decompensated heart failure. Drugs 63:2651–2671

    Article  PubMed  CAS  Google Scholar 

  • Jiang Q, Hu D, Xiao N, Du W, Liu R, Min J, Wang Q, Liu L (2002) Therapeutic effect of 6-[4-(4’-pyridyl)aminophenyl]-4,5-dihydro-3(2H)-pyridazinone on hemorrhagic shock and its mechanisms in rabbits and rats. Zhongguo Yaolixue Yu Dulixue Zazhi 16:102–105

    CAS  Google Scholar 

  • Kasikcioglu HA, Cam N (2006) A review of levosimendan in the treatment of heart failure. Vasc Health Risk Manag 2:389–400

    Article  PubMed  CAS  Google Scholar 

  • Kawasumi H, Abe Y, Ishibashi A, Kitada Y (1999) MCI-154, a Ca2+ sensitizer, increases survival in cardiomyopathic hamsters. Eur J Pharmacol 372:175–178

    Article  PubMed  CAS  Google Scholar 

  • Kerdesky FA, Leanna MR, Zhang JI, Wenke LI, Lallaman JE, Jianguo JI, Morton HE (2006) An efficient multikilogram synthesis of ABT-963: a selective COX-2 inhibitor. Org Pro Res Dev 10:512–517

    Article  CAS  Google Scholar 

  • Kitada Y, Kobayashi M, Narimatsu A, Ohizumi Y (1989) Potent stimulation of myofilament force and adenosine triphosphatase activity of canine cardiac muscle through a direct enhancement of troponin C calcium binding by MCI-154, a novel cardiotonic agent. J Pharmacol Exp Ther 250:272–277

    PubMed  CAS  Google Scholar 

  • Korvald C, Nordhaug DO, Steensrud T, Aghajani E, Myrmel T (2002) Vasodilation and mechanoenergetic inefficiency dominates the effect of the “Ca2+-sensitizer” MCI-154 in intact pigs. Scand Cardiovasc J 36:172–179

    PubMed  CAS  Google Scholar 

  • Kubo SH (1997) Effects of pimobendan on exercise tolerance and quality of life in patients with heart failure. Cardiology 88:21–27

    Article  PubMed  CAS  Google Scholar 

  • Kumar D, Carron R, La Calle CD, Jindal DP, Bansal R (2008) Synthesis and evaluation of 2-substituted-6-phenyl-4,5-dihydropyridazin-3(2H)-ones as potent inodilators. Acta Pharm 4:393–405

    Google Scholar 

  • Laguna R, Montero A, Cano E, Ravina E, Sotelo E, Estevez I (1996) 6-Aryl-5-substituted pyridazinones as platelet aggregation inhibitors with non cAMP PDE-3 based mechanism. Acta Pharma Hung 66:S43–S45

    CAS  Google Scholar 

  • Lazewska D, Kiec-Kononowicz K (2010) Recent advances in histamine H3 receptor antagonists/inverse agonists. Expert Opin Ther Pat 20:1147–1169

    Article  PubMed  CAS  Google Scholar 

  • Lee SG, Kim JJ, Kweon DH, Kang YJ, Cho SD, Kim SK, Yoon YJ (2004) Recent progress in pyridazin-3(2H)-ones chemistry. Curr Med Chem 8:1463–1480

    CAS  Google Scholar 

  • Malinka W, Redzicka A, Lozach O (2004) New derivatives of pyrrolo[3,4-d] pyridazinone and their anticancer effects. IL Farmaco 59:457–462

    Article  PubMed  CAS  Google Scholar 

  • Malinka W, Redzicka A, Jastrzębska-Więsek M, Filipek B, Dybała M, Karczmarzyk Z, Urbańczyk-Lipkowska Z, Kalicki P (2011) Derivatives of pyrrolo[3,4-d]pyridazinone, a new class of analgesic agents. Eur J Med Chem 46:4992–4999

    Article  PubMed  CAS  Google Scholar 

  • Manetti F, Corelli F, Strappaghetti G, Botta M (2002) Arylpiperazines with affinity towards α1-adrenergic receptors. Curr Med Chem 9:1303–1321

    Article  PubMed  CAS  Google Scholar 

  • Margaretha VM, Bommele KM, Boss H, Hatzelmann A, Slingerland MV, Sterk GJ, Timmerman H (2003) Synthesis and structure-activity relationships of cis-tetrahydrophthalazinone/pyridazinone hybrids: a novel series of potent dual PDE3/PDE4 inhibitory agents. J Med Chem 46:2008–2016

    Article  Google Scholar 

  • Mathieu S, Crai G (2011) Levosimendan in the treatment of acute heart failure, cardiogenic and septic shock: a critical review. J Iran Chem Soc 12:1

    Google Scholar 

  • Matyus P (1998) 3(2H)-Pyridazinones: some recent aspects of synthetic and medicinal chemistry. J Het Chem 35:1075–1089

    Article  CAS  Google Scholar 

  • Matyus p, Czako K (1993) 4,5-Dihalo-3(2H)-pyridazinones—regiochemistry and synthetic utility for fused pyridazine derivatives. Trends Heterocyclic Chem 3:249–264

    Google Scholar 

  • Meade EA, Wortin LL, Drach JC, Townsend LB (1993) Synthesis, antiproliferative and antiviral activity of 4-amino-1(β-D-ribofuranosyl)pyrrolo[2,3-d]pyridazin-7(6H)-one and related derivatives. J Med Chem 36:3834–3842

    Article  PubMed  CAS  Google Scholar 

  • Miyake S, Shiga H, Koike H (1989) Arterial and venous vasodilator actions of RS-1893, a novel cardiotonic agent, in the hind limb preparation of the dog. J Cardiovasc Pharmacol 14:526–533

    Article  PubMed  CAS  Google Scholar 

  • Montesano F, Barlocco D, Dal Piaz V, Leonardi A, Poggesi E, Fanelli F (1998) Isoxazolo-[3,4-d]-pyridazin-7-(6H)-ones and their corresponding 4,5-disubstituted-3-(2H)-pyridazinone analogues as new substrates for α1-adrenoceptor selective antagonists: synthesis, modeling and binding studies. Bio Org Med Chem 6:925–935

    Article  CAS  Google Scholar 

  • Mylari BL, Armento SJ, Beebe DA, Conn EL, Coutcher JB, Dina MS (2003) A highly selective, non-hydantoin, non-carboxylic acid inhibitor of aldose reductase with potent oral activity in diabetic rat models: 6-(5-chloro-3-methylbenzofuran-2-sulfonyl)-2H-pyridazin-3-one. J Med Chem 46:2283–2286

    Article  PubMed  CAS  Google Scholar 

  • Narimatsu A, Kitada Y, Satoh N, Suzuki R, Okushima H (1987) Cardiovascular pharmacology of 6-[4-(4’-pyridyl)aminophenyl]-4,5-dihydro-3(2H)-pyridazinone hydrochloride, a novel and potent cardiotonic agent with vasodilator properties. Arzneim-Forsch 37:398–406

    CAS  Google Scholar 

  • Purohit DM, Shah VH (1998) Novel method for synthesis and antimicrobial activity of 2-arylsulpho-6-hydroxy/chloro/hydrazine/carboxy-methoxy-3(2H)-pyridazinones. Ind J Chem 37:956–960

    Google Scholar 

  • Rathish IG, Javed K, Bano S, Ahmad S, Alam MS, Pillai KK (2009) Synthesis and blood glucose lowering effect of novel pyridazinone substituted benzene sulfonylurea derivatives. Eur J Med Chem 44:2673–2678

    Article  PubMed  CAS  Google Scholar 

  • Regina MB (2006) Cyclooxygenase: past, present and future. J Therm Biol 31:208–219

    Article  Google Scholar 

  • Rohet E, Rubat C, Coudert P, Albuisson E, Couquelet J (1996) Synthesis and trazodone like analgesic activity of 4-phenyl-6-aryl-2-[3-(4-arylpiperazin-1-yl)propyl]pyridazin-3-ones. Chem Pharm Bull 44:980

    Article  PubMed  CAS  Google Scholar 

  • Rossotti R, Rusconi S (2009) Efficacy and resistance of recently developed non-nucleoside reverse transcriptase inhibitors for HIV-1. HIV Therapy 3:63–77

    Article  CAS  Google Scholar 

  • Rubat C, Coudert P, Tronche P, Bastide J, Bastide P, Privat AM (1989) Synthesis and pharmacological evaluation of N-substituted 4,6-diaryl-3-pyridazinones as analgesic, anti-inflammatory and antipyretic agents. Chem Pharm Bull 37:2832–2835

    Article  PubMed  CAS  Google Scholar 

  • Rubat C, Coudert P, Albuisson E, Bastide J, Couquelet J, Tronche P (1992) Synthesis of Mannich bases of aryldenepyridazinones as analgesic agents. J Pharm Sci 81:1084

    Article  PubMed  CAS  Google Scholar 

  • Santagati NA, Duro E, Caruso A, Trombadore S, Amico-Roxas M (1985) Synthesis and pharmacological study of a series of 3(2H)-pyridazinones as analgesic and anti-inflammatory agents. IL Farmaco 40:921

    CAS  Google Scholar 

  • Sata M, Sugiura S, Yamashita H, Fujita H, Momomura S, Serizawa T (1995) MCI-154 increases Ca2+ sensitivity of reconstituted thin filament. A study using a novel in vitro motility assay technique. Circ Res 76:626–633

    Article  PubMed  CAS  Google Scholar 

  • Schudt C, Winder S, Mueller B, Ukena D (1991) Zardaverine as a selective inhibitor of phosphodiesterase isozymes. Biochem Pharmacol 42:153–162

    Article  PubMed  CAS  Google Scholar 

  • Siddiqui AA, Mishra R, Shaharyar M (2010) Synthesis, characterization and antihypertensive activity of pyridazinone derivatives. Eur J Med Chem 45:2283–2290

    Article  PubMed  CAS  Google Scholar 

  • Sivakumar R, Anabalagan N, Gunasekaran V, Leonard JT (2003) Synthesis and anticonvulsant activity of novel 1-substituted-1,2-dihydro-pyridazine-3,6-diones. Biol Pharm Bull 26:1407–1411

    Article  PubMed  CAS  Google Scholar 

  • Sonmej M, Berber L, Akbas B (2005) Synthesis, antibacterial and antifungal activity of some new pyridazinone metal complexes. Eur J Med Chem 41:101–105

    Article  Google Scholar 

  • Steuber H, Zentgraf M, Podjarny A, Heine A (2006) High-resolution crystal. Structure of aldose reductase complexed with the novel sulfonyl-pyridazinone inhibitor exhibiting an alternative active site anchoring group. J Mol Biol 356:45–56

    Article  PubMed  CAS  Google Scholar 

  • Sukuroglu M, Ergun BC, Unlu M, Sahin MF, Kupeli E, Yesilada E, Banoglu E (2005) Synthesis, analgesic, and anti-inflammatory activities of [6-(3,5-dimethyl-4-chloropyrazole-1-yl)-3(2H)-pyridazinon-2-yl]acetamides. Arch Pharm Res 5:509–517

    Article  Google Scholar 

  • Tao M, Raddatz R, Aimone LD, Hudkins RL (2011) Synthesis and structure-activity relationships of 4,5-fused pyridazinones as histamine H3 receptor antagonists. Bioorg Med Chem Lett 21:6126–6130

    Article  PubMed  CAS  Google Scholar 

  • Tsubaki K, Taniguchi K, Tabuchi S, Okitsu O, Hattori K, Seki J, Sakane K, Tanaka H (2000) A novel pyridazinone derivative as a nonprostanoid PGI2 agonist. Bio Org Med Chem Lett 10:2787–2790

    Article  CAS  Google Scholar 

  • Ungureanu M, Mangaalagiu I, Grasu G, Petrovanu M (1997) Antimicrobial activity of some new pyridazium compounds. Annal Pharm Franc 55:69–72

    CAS  Google Scholar 

  • Warren SE, Kihara Y, Pesaturo J, Gwathmey JK, Phillips P, Morgan JP (1989) Inotropic and lusitropic effects of MCI-154 (6-[4-(4-pyridyl)-aminophenyl]-4,5-dihydro-3(2H)-pyridazinone) on the human myocardium. J Mol Cell Cardiol 21:1037–1045

    Article  PubMed  CAS  Google Scholar 

  • Xu P, Wang SY, Chen Y, Liu WO, Tao C (1991) Studies on synthesis, anticonvulsant activity and the structure activity relationship of 6-(substitutedphenyl)-3(2H) pyridazinones. Yao Xue Xue Bao 26:656–660

    PubMed  CAS  Google Scholar 

  • Xu YJ, Zhao SY, Wang ZC, Liu SC, Sun WJ, Zhao SC (1999) New synthesis of cardiotonic agent pimobendan. Hecheng Huaxue 7:194–197

    CAS  Google Scholar 

  • Yamada T, Nobuhara Y, Yamaguchi A, Ohki M (1982) Pyridazinones. 1. Synthesis and antisecretory and antiulcer activities of thioamide derivatives. J Med Chem 25:975–982

    Article  PubMed  CAS  Google Scholar 

  • Yamada T, Nobuhara Y, Shimamura H, Tsukamoto Y, Yoshihara K, Yamaguchi A, Ohki M (1983a) Pyridazinones. 2. Synthesis and antisecretory and antiulcer activities of thiourea and 2-cyanoguanidine derivatives. J Med Chem 26:373–381

    Article  PubMed  CAS  Google Scholar 

  • Yamada T, Shimamura H, Tsukamoto Y, Yamaguchi A, Ohki M (1983b) Pyridazinones. 3. Synthesis and antisecretory and antiulcer activities of 2-cyanoguanidine derivatives. J Med Chem 26:1144–1149

    Article  PubMed  CAS  Google Scholar 

  • Zhou G, Ting PC, Aslanian R, Cao J, Kim DW, Kuang R, Lee JF, Schwerdt J, Wu H, Herr AJ, Yang J, Lam S, Wainhaus S, Black TA, Mcnicholas PM, Xu Y, Walker SS (2011) SAR studies of pyridazinone derivatives as novel glucan synthase inhibitors. Bioorg Med Chem Lett 21:2890–2893

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. University Institute of Pharmaceutical Sciences, Panjab University, Sector-14, Chandigarh, 160014, India

    Ranju Bansal & Sridhar Thota

Authors
  1. Ranju Bansal
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sridhar Thota
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ranju Bansal.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bansal, R., Thota, S. Pyridazin-3(2H)-ones: the versatile pharmacophore of medicinal significance. Med Chem Res 22, 2539–2552 (2013). https://doi.org/10.1007/s00044-012-0261-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00044-012-0261-1

Keywords

Search

Navigation